September 16, 2026 | A Big Week for Korea 💪

Issue #53 · September 16

View Archive | Subscribe | Partners With Us

From Members to Global: Covering the Entire Bio Industry

Korea Bio is moving- On and Off the stage! 💪

This week's edition highlights BIX 2026, which we host, new milestones from KoreaBIO member companies, and the latest moments from our work across Korea's bioindustry.

Stay tuned till the end for more K-Bio updates!

THIS WEEK:

BIX 2026 Names Canada as Country of Honor, Showcasing Bioindustry Trends from BCI to Biotech Foods

In particular, a Featured Session with Dion M. Kelly, Co-founder and CEO of Canadian BCI company Possibility Neurotechnologies, will be held at The Platz on October 30, the final day of the event. — THE BIO

Samsung Bio, waiting to break into peptides, nets $262M manufacturing deal with unnamed EU pharma

As Samsung Biologics works to close a massive buyout to branch out into peptides, the Korean CDMO’s bread-and-butter contracting work continues to gin up big-ticket contracts from the drug industry. — Fierce Pharma

“It Endured 25 Years of Losses Before Its First New Drug”...The Company That Stayed the Course Now Has a Market Cap of 115 Trillion Won

He also offered practical advice to Korean biotech companies that, due to funding shortages, transfer their pipelines at bargain prices during Phase 1 or Phase 2 clinical trials. — Maeil Business

KoreaBIO MEMBER NEWS

🏆 Congratulations to the winners of Prix Galien Korea 2026! 🎉

Widely regarded as the “Nobel Prize of Biopharma,” the Prix Galien honors groundbreaking achievements and innovation in the life sciences.

The inaugural Prix Galien Korea Awards celebrated the country's growing biotech capabilities, with KoreaBIO member companies earning top honors across multiple categories. Their recognition reflects the diversity and excellence of Korea’s biotech innovation and its increasing presence on the global stage.

🏅 Best Pharmaceutical Product - Oscotec × YUHAN ★Member Company
🏅 Best Biotechnology Product - BIONEER ★Member Company
🏅 Best Medical Technology - ALTEOGEN ★Member Company

🏅 Best Digital Health Solution - Dot
🏅 Best Startup - ADEL

NovMetaPharma CTO Hoe-Yune Receives Vice Minister's Commendation from the Ministry of Science and ICT.

HUINNO Completes Medical Device Modification Certification to Expand Intended Users of ‘MEMO Patch 2 to Infants.

ProBio to Host "From Concept to Cell Line: Advancing Breakthrough Biologics" Webinar on September 17.

BXPLANT and PCMO to Host "New Drug Development Validation Support Network" on October 14.

Asleep Signs MOU with Air Liquide Healthcare to Expand Home Healthcare Business in 30 countries.

Trial Informatics to Host "AI Imaging Biomarker Symposium" on October 1.

Oscotec and YUHAN Win Best Pharmaceutical Product at 2026 Prix Galien Korea Awards.

BIONEER Wins Best Biotechnology Product at 2026 Prix Galien Korea Awards.

ALTEOGEN Wins Best Medical Technology at 2026 Prix Galien Korea Awards.

IVIM Technology Holds Luncheon Seminar at K-Brain 2026 on Longitudinal Intravital In Vivo Brain Imaging in Rodents.

👥 View More Members Companies

WHAT WE'VE BEEN UP TO

Heal the World! 🪄

KoreaBIO hosted the 2026 Biohealthcare Media Day in Seoul on September 15, bringing together members of the media for meaningful conversations, networking, and connection.

More Photos →

Jurie Hwang, Director of International & Public Relations at KoreaBIO, joined the discussion, titled "A Journey of Innovation in K-Bio: Advice from Global Leaders". The session explored strategies for the sustainable growth and global advancement of Korea’s biotechnology industry.

More Photos →

Seung-Kyou Lee, Vice President of the KoreaBIO, delivered a keynote speech at the 2026 International Conference on the Green Bio Industry, held in Pohang on September 2, 2026.

More Photos →